Harvard Bioscience Acquires Electrophysiology Firms

Karl-Heinz Boven and Andreas Möller, founders of MCS, will become directors of the MCS subsidiary. TBSI President Dr. James Morizio, will become director of R&D, Wireless Platform.

Holliston, MA 10/1/14—Life sciences firm Harvard Bioscience has purchased German firm Multi Channel Systems MCS, a supplier of instruments for extracellular recording and stimulation, for €7.5 million ($9.5 million = €0.79 = $1) in cash. It also bought US-based Triangle BioSystems (TBSI), a provider of wireless neural-interface equipment for in vivo– neuroscience research, for $1.6 million, net of acquired cash. Combined, the acquisitions are expected to add $7.5–$8.5 million to revenues in 2015, and they are expected to be accretive to 2015 earnings. Harvard stated that the acquisitions complement its Warner Instruments brand. MCS’s line of in vitro–and in–vivo electrophysiology–microelectrode arrays, patch clamps and software complements Warner’s in vitro electrophysiology line and broadens its selection of patch clamps. TBSI’s products complement the behavioral neuroscience devices offered by Harvard Bioscience’s Panlab and Coulbourn Instruments subsidiaries.

< | >